Are sodium-glucose cotransporter-2 inhibitors safe for patients with diabetes and cancer?
Credit: Pixabay/CC0 Public Domain Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have heart- and kidney-related benefits for patients with and without diabetes that go beyond their initial indication for lowering blood sugar levels. …
Are sodium-glucose cotransporter-2 inhibitors safe for patients with diabetes and cancer? Read More